Lucid Diagnostics Inc (LUCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -3,653 | -8,280 | -5,549 |
| Depreciation Amortization | 3 | 0 | N/A |
| Accounts payable and accrued liabilities | -1,269 | N/A | 622 |
| Other Working Capital | -1,273 | 223 | 102 |
| Other Operating Activity | 2,877 | 2,428 | 871 |
| Operating Cash Flow | $-3,315 | $-5,629 | $-3,953 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -9 | 0 | N/A |
| Investing Cash Flow | $-9 | $0 | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | N/A | N/A | 5 |
| Other Financing Activity | 3,300 | 5,584 | 3,979 |
| Financing Cash Flow | $3,300 | $5,584 | $3,984 |
| Beginning Cash Position | 111 | 156 | 156 |
| End Cash Position | 87 | 111 | 187 |
| Net Cash Flow | $-24 | $-45 | $31 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,315 | -5,629 | -3,953 |
| Capital Expenditure | -9 | N/A | N/A |
| Free Cash Flow | -3,324 | -5,629 | -3,953 |